Aetos Biologics is a Silicon Valley based company committed to bringing biosimilars to the world market faster and cheaper. By creating high quality, IND-ready packages, Aetos saves its partners 2-3 years in early development work, expediting the timeline into the clinic and subsequent market launch. Using the latest advances in molecular biology, cell culture, process sciences, and operations, we ensure our partners have an economically advantageous market position. Our Team has extensive experience developing several biosimilars, innovator biotherapeutics and platform technolgies.

Aetos Biologics has several biosimilars in its development pipeline and is currently looking for strategic partnerships. Following infographic shows the benefits of a strategic partnership with Aetos: